Personalized Medicine Market Landscape Limelighted in New Kelly Scientific Publications Study Available at MarketPublishers.com

02 Jul 2015 • by Natalie Aster

LONDON – The world’s core personalized medicine market is projected to worth more than USD 60 billion by end-2019. The market consists of targeted therapeutics and companion diagnostics and is presently valued at USD 42 billion. This market is led by oncology, infectious and cardiovascular diseases treatment and diagnostics.

Individualized, targeted or personalized medicine is aimed at boosting the efficacy of therapeutics through companion diagnostics (theranostics) and genetic testing. Personalized therapeutics and related companion diagnostics will likely be more specific and efficient, by that giving pharmaceutical and/or biotechnology companies a huge advantage to recover research & development costs. Personalized medicine is set to decrease the incidence of adverse drug reactions (ADRs) and hence have an immense influence on the economics of health care. Developmental and diagnostic firms are likely to reap benefits from lower costs of discovery and commercialization and also more specific market sub-types. 

Affymetrix, 23andMe, Nodality, CuraGen, Celldex Therapeutics, Atossa Genetics, Genelex, Illumina, Myriad, Claritas Genomics Admera Health, and Qiagen are some of the leading players involved in the market.

New research report “Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” created by Kelly Scientific Publications gives revolutionary, unbiased insights into the market for personalized healthcare on a global scale. The report gives an all-round analysis of the market size, offers granular market segmentation, reviews cutting-edge technologies, and also looks at business and economic settings. The personalized medicine market is examined globally and in the USA, based on company, by geography, segment, sub-market, and by therapy. The report presents a heap of financial data and corporate strategy information. SWOT, economic and regulatory environment specifics can also be found in the study. The research report thoroughly examines the various influential market participants, giving details about their key products, operations, financials and business strategies.

Report Details:

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
Published: July, 2015
Pages: 279
Price: US$ 3,400.00

More new studies by the publisher can be found at Kelly Scientific Publications page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 
MarketPublishers.com